Overview
Yuki Hiroshima practices in Nagano, Japan. Hiroshima is rated as an Experienced expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). Their top areas of expertise are Pure Red Cell Aplasia, T-Cell Lymphoma, Pernicious Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow AspirationHiroshima isDistinguished. Learn about Bone Marrow Aspiration.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Hiroshima isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Anaplastic Large Cell LymphomaHiroshima isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- AnemiaHiroshima isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell LymphomaHiroshima isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Atypical PneumoniaHiroshima isExperienced. Learn about Atypical Pneumonia.
- Autoimmune Hemolytic AnemiaHiroshima isExperienced. Learn about Autoimmune Hemolytic Anemia.